In this episode of The Biotech Startups Podcast, Siren Biotechnology CEO & Founder, Nicole Paulk unpacks why being a first-time female technical academic founder CEO — "the worst possible thing you could be" — was actually the best CEO training imaginable. She breaks down how her scrappy academic mindset stretched a $6M seed round across three and a half years, why going all-in on unglamorous CMC optimization was Siren Biotechnology's most important early decision, and why capital efficiency is a company-defining mindset, not just a financial strategy. Nicole also opens up about the loneliness of the founder CEO role, the toxic culture of "competitive complaining" at industry meetups, and the profound weight of Siren's recent FDA IND clearance — and what it means to be on the verge of dosing the very first brain cancer patient at UCSF.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related